1. Home
  2. GENC vs KROS Comparison

GENC vs KROS Comparison

Compare GENC & KROS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gencor Industries Inc.

GENC

Gencor Industries Inc.

HOLD

Current Price

$15.26

Market Cap

222.5M

Sector

Industrials

ML Signal

HOLD

Logo Keros Therapeutics Inc.

KROS

Keros Therapeutics Inc.

HOLD

Current Price

$12.03

Market Cap

206.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GENC
KROS
Founded
N/A
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Construction/Ag Equipment/Trucks
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
222.5M
206.0M
IPO Year
1995
2020

Fundamental Metrics

Financial Performance
Metric
GENC
KROS
Price
$15.26
$12.03
Analyst Decision
Strong Buy
Buy
Analyst Count
1
7
Target Price
$17.60
$21.86
AVG Volume (30 Days)
28.3K
308.9K
Earning Date
02-06-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
8.08
146.00
EPS
0.50
N/A
Revenue
$48,943,000.00
$243,864,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$25.51
$2,751.79
P/E Ratio
$30.40
N/A
Revenue Growth
N/A
N/A
52 Week Low
$12.22
$9.69
52 Week High
$17.40
$22.55

Technical Indicators

Market Signals
Indicator
GENC
KROS
Relative Strength Index (RSI) 57.28 62.62
Support Level $14.41 $10.57
Resistance Level $15.50 $12.43
Average True Range (ATR) 0.35 0.53
MACD 0.03 0.15
Stochastic Oscillator 81.25 93.13

Price Performance

Historical Comparison
GENC
KROS

About GENC Gencor Industries Inc.

Gencor Industries Inc and its subsidiaries are a manufacturer of heavy machinery used in the production of highway construction materials and environmental control equipment. The Company's products are manufactured in the United States and sold through a combination of Company sales representatives and independent dealers and agents. The Company has one reporting segment, equipment for the highway construction industry. The Company's principal core products include asphalt pavers, hot mix asphalt plants, combustion systems, and fluid heat transfer systems. It operates in the United States, Canada, and other foreign countries, with the majority of revenue coming from the United States.

About KROS Keros Therapeutics Inc.

Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.

Share on Social Networks: